Outlook Therapeutics (OTLK) Net Cash Flow: 2015-2024
Historic Net Cash Flow for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to -$8.5 million.
- Outlook Therapeutics' Net Cash Flow fell 89.93% to -$11.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $5.4 million, marking a year-over-year decrease of 13.94%. This contributed to the annual value of -$8.5 million for FY2024, which is 241.19% down from last year.
- As of FY2024, Outlook Therapeutics' Net Cash Flow stood at -$8.5 million, which was down 241.19% from $6.0 million recorded in FY2023.
- Over the past 5 years, Outlook Therapeutics' Net Cash Flow peaked at $6.0 million during FY2023, and registered a low of -$8.5 million during FY2024.
- In the last 3 years, Outlook Therapeutics' Net Cash Flow had a median value of $2.9 million in 2022 and averaged $150,071.
- Per our database at Business Quant, Outlook Therapeutics' Net Cash Flow soared by 105.35% in 2023 and then tumbled by 241.19% in 2024.
- Outlook Therapeutics' Net Cash Flow (Yearly) stood at $4.5 million in 2020, then slumped by 57.05% to $1.9 million in 2021, then surged by 50.39% to $2.9 million in 2022, then skyrocketed by 105.35% to $6.0 million in 2023, then tumbled by 241.19% to -$8.5 million in 2024.